SERPING1
Basic information
Region (hg38): 11:57597387-57619171
Previous symbols: [ "C1NH" ]
Links
Phenotypes
GenCC
Source:
- hereditary angioedema type 1 (Supportive), mode of inheritance: AD
- hereditary angioedema type 2 (Supportive), mode of inheritance: AD
- C1 inhibitor deficiency (Supportive), mode of inheritance: AD
- hereditary angioedema with C1Inh deficiency (Strong), mode of inheritance: AD
- hereditary angioedema with C1Inh deficiency (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Angioedema, hereditary, 1 | AD/AR | Allergy/Immunology/Infectious | Medical treatment (eg, with C1 inhibitor concentrate, ecallantide, icatabant) may be beneficial to prevent and/or treat acute attacks | Allergy/Immunology/Infectious; Gastrointestinal | 4393526; 4551861; 792688; 7091182; 3587308; 3653633; 3056508; 3693762; 2723063; 2365061; 2296585; 1885769; 1684567; 1339401; 1459574; 8396558; 8330878; 7618673; 7883978; 8755917; 8628358; 11700154; 11743247; 15971231; 16470590; 16813612 ; 17137866; 17502473; 19752569; 20695852; 20818887; 20818888; 20818886; 21208117; 21864911; 22748405; 22800873; 22831796; 22882460; 23123409; 23437219; 23583915; 23607500; 23678554; 23689237 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (448 variants)
- Hereditary_angioedema_type_1 (283 variants)
- Inborn_genetic_diseases (61 variants)
- Hereditary_angioedema_with_C1Inh_deficiency (35 variants)
- SERPING1-related_disorder (20 variants)
- Angioedema (14 variants)
- C1_inhibitor_deficiency (9 variants)
- not_specified (7 variants)
- Hereditary_C1_esterase_inhibitor_deficiency_-_dysfunctional_factor (6 variants)
- Complement_component_4,_partial_deficiency_of,_due_to_dysfunctional_c1_inhibitor (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SERPING1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000062.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 95 | 100 | ||||
| missense | 57 | 67 | 174 | 30 | 332 | |
| nonsense | 50 | 51 | ||||
| start loss | 3 | 3 | ||||
| frameshift | 123 | 16 | 140 | |||
| splice donor/acceptor (+/-2bp) | 34 | 41 | ||||
| Total | 268 | 90 | 178 | 126 | 5 |
Highest pathogenic variant AF is 0.0000065719432
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SERPING1 | protein_coding | protein_coding | ENST00000278407 | 7 | 17467 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.964 | 0.0365 | 125733 | 0 | 1 | 125734 | 0.00000398 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.06 | 213 | 261 | 0.815 | 0.0000143 | 3275 |
| Missense in Polyphen | 31 | 75.798 | 0.40898 | 1010 | ||
| Synonymous | -0.190 | 111 | 108 | 1.02 | 0.00000608 | 1040 |
| Loss of Function | 3.31 | 1 | 14.7 | 0.0680 | 6.54e-7 | 195 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000615 | 0.0000615 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.00 | 0.00 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Activation of the C1 complex is under control of the C1- inhibitor. It forms a proteolytically inactive stoichiometric complex with the C1r or C1s proteases. May play a potentially crucial role in regulating important physiological pathways including complement activation, blood coagulation, fibrinolysis and the generation of kinins. Very efficient inhibitor of FXIIa. Inhibits chymotrypsin and kallikrein. {ECO:0000269|PubMed:8495195}.;
- Disease
- DISEASE: Hereditary angioedema (HAE) [MIM:106100]: An autosomal dominant disorder characterized by episodic local swelling involving subcutaneous or submucous tissue of the upper respiratory and gastrointestinal tracts, face, extremities, and genitalia. Hereditary angioedema due to C1 esterase inhibitor deficiency is comprised of two clinically indistinguishable forms. In hereditary angioedema type 1, serum levels of C1 esterase inhibitor are decreased, while in type 2, the levels are normal or elevated, but the protein is non-functional. {ECO:0000269|PubMed:12773530, ECO:0000269|PubMed:1363816, ECO:0000269|PubMed:1451784, ECO:0000269|PubMed:14635117, ECO:0000269|PubMed:16409206, ECO:0000269|PubMed:2118657, ECO:0000269|PubMed:2296585, ECO:0000269|PubMed:22994404, ECO:0000269|PubMed:2365061, ECO:0000269|PubMed:24456027, ECO:0000269|PubMed:3178731, ECO:0000269|PubMed:7814636, ECO:0000269|PubMed:7883978, ECO:0000269|PubMed:8172583, ECO:0000269|PubMed:8529136, ECO:0000269|PubMed:8755917, ECO:0000269|Ref.41}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Complement and coagulation cascades - Homo sapiens (human);Pertussis - Homo sapiens (human);Human Complement System;Dengue-2 Interactions with Complement and Coagulation Cascades;Complement and Coagulation Cascades;intrinsic prothrombin activation pathway;Innate Immune System;Immune System;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Intrinsic Pathway of Fibrin Clot Formation;Hemostasis;Formation of Fibrin Clot (Clotting Cascade);Regulation of Complement cascade;Complement cascade
(Consensus)
Recessive Scores
- pRec
- 0.215
Intolerance Scores
- loftool
- 0.00565
- rvis_EVS
- -0.65
- rvis_percentile_EVS
- 16.44
Haploinsufficiency Scores
- pHI
- 0.105
- hipred
- Y
- hipred_score
- 0.594
- ghis
- 0.599
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.458
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Serping1
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype;
Gene ontology
- Biological process
- negative regulation of complement activation, lectin pathway;platelet degranulation;complement activation, classical pathway;aging;blood coagulation, intrinsic pathway;blood circulation;negative regulation of endopeptidase activity;regulation of complement activation;fibrinolysis;innate immune response
- Cellular component
- extracellular region;extracellular space;platelet alpha granule lumen;collagen-containing extracellular matrix;extracellular exosome;blood microparticle
- Molecular function
- serine-type endopeptidase inhibitor activity;protein binding